RecruitingPhase 4NCT06763731

Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery

Sponsor

National Taiwan University Hospital

Enrollment

150 participants

Start Date

May 2, 2024

Study Type

INTERVENTIONAL

Conditions

Regular use of Systane COMPLETE in dry eye subjects before cataract surgery may optimize the ocular surface.

Min Age: 20 YearsMax Age: 85 Years

The subjects aged 20-85 years, with normal cognitive function and capable of answering related questionnaires who require phacoemulsification and intraocular lens implantation under topical anaesthesia, are the eligible candidates.

Unable to answer the questions in the dry eye survey.
Ocular trauma or ocular surgery in the planned surgical eye, active ocular infection, and obvious abnormalities in ocular surface or eyelid margins other than MGD cause decreased visual acuity other than cataracts.
Dry eye signs: Corneal Fluorescein Staining CFS (+) to exclude any corneal abnormalities or epithelial defect
Systemic drug use, including tetracycline derivatives, antihistamines, and isotretinoin.
Using dry eye medication at screening stage

Interested in this trial?

Get notified about updates and connect with the research team.

DRUGSystane COMPLETE

Preop dry eye management using Systane COMPLETE can help to optimize the ocular surface.

National Taiwan University Hospital

Taipei, Taiwan, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT06763731